José E. Guimarães

Universidade do Porto — Portugal

Medicine · Health Sciences

17h-index1.5kcitations50works1.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Multiple Myeloma Research and Treatments(15), MicroRNA in disease regulation(10), Acute Myeloid Leukemia Research(10), RNA Interference and Gene Delivery(8), Chronic Myeloid Leukemia Treatments(8)

Publications50 total

MicroRNA-665 and its potential role in drug response and survival outcomes in multiple myeloma: a preliminary study
Frontiers in Pharmacology·2025· 2 citedOpen Access
The Role of MicroRNAs in Mature B-Cell Neoplasias Drug Resistance
Elsevier eBooks·2024
Detection of Measurable Residual Disease Biomarkers in Extracellular Vesicles from Liquid Biopsies of Multiple Myeloma Patients—A Proof of Concept
International Journal of Molecular Sciences·2022· 16 citedOpen Access
P-057: Studying microRNAs from extracellular vesicles as potential biomarkers in liquid biopsies of multiple myeloma patients
Clinical Lymphoma Myeloma & Leukemia·2022
P-058: Identifying microRNAs as potential biomarkers of drug resistance in multiple myeloma patients: proof-of-concept study
Clinical Lymphoma Myeloma & Leukemia·2022
Measurable Residual Disease in Extracellular Vesicles from Bone Marrow and Peripheral Blood of Patients with Multiple Myeloma: A Proof-of-Concept Study
Blood·2021
Patient Blood Management em Oncologia – é possível?
2021Open Access
miRNAs mediated drug resistance in hematological malignancies
Seminars in Cancer Biology·2021· 31 cited
The Role of Extracellular Vesicles in the Hallmarks of Cancer and Drug Resistance
Cells·2020· 165 citedOpen Access
Impact of the type of anthracycline and of stem cell transplantation in younger patients with acute myeloid leukaemia: Long‐term follow up of a phase <scp>III</scp> study
American Journal of Hematology·2020· 17 citedOpen Access
Multiple Myeloma: Available Therapies and Causes of Drug Resistance
Cancers·2020· 215 citedOpen Access
Correction to: Update on management and progress of novel therapeutics for R/R AML: an Iberian expert panel consensus
Annals of Hematology·2020· 3 cited
Aggressive Central Nervous System Relapse after Autologous Stem Cell Transplant in Multiple Myeloma: Case Reports and Literature Review
Case Reports in Hematology·2020· 7 citedOpen Access
Update on management and progress of novel therapeutics for R/R AML: an Iberian expert panel consensus
Annals of Hematology·2019· 39 cited
Negative MR<sup>4·0</sup> chronic myeloid leukaemia and its possible implications for treatment‐free remission
British Journal of Haematology·2019· 1 citedOpen Access
Results of Autologous and Allogeneic Transplantation in Patients with Primary Plasma Cell Leukemia: A Large Retrospective Analysis of the Chronic Malignancies Working Party of the EBMT
Blood·2018· 4 cited
Real-life data on safety and efficacy of autologous stem cell transplantation in elderly patients with multiple myeloma
Annals of Hematology·2018· 29 citedOpen Access
Pyoderma gangrenosum and erythema elevatum diutinum associated with a high-risk myelodysplastic syndrome: case report
Hematology Transfusion and Cell Therapy·2018· 4 citedOpen Access
Bortezomib: Potential Key Role in the Treatment of Multiple Myeloma-Related Acquired Hemophilia A
Seminars in Thrombosis and Hemostasis·2016· 7 cited
Histiocitose de Largerhans no Adulto: Experiência de Dois Hospitais Portugueses
Acta Médica Portuguesa·2014· 5 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

M. Helena Vasconcelos(22), Rui Bergantim(16), Raquel T. Lima(10), Hugo Seca(9), Fernanda Trigo(8), Sara Peixoto da Silva(7), Hugo R. Caires(6), Stefan Suciu(6), Petra Muus(6), Sergio Amadori(6), Xavier Thomas(6), Paola Fazi(6), Marco Vignetti(6), R. Willemze(5), Dominik Selleslag(5), François Lefrère(5), Zwi Berneman(5), Théo de Witte(5), Jean‐Pierre Marie(5), Mélanie A. G. Barbosa(4)